Webinar Date and Time: Wednesday, June 14, 2023, at 4:00 PM
Stem cell transplants are a type of treatment option for lymphoma patients. A stem cell transplant involves treatment with an aggressive therapy first to destroy cancer, followed by an infusion of your own stem cells (autologous) or a donor’s stem cells (allogeneic) to replace the cells destroyed by the cancer treatment. The stem-cell transplant process is complex and may be used as a treatment option for you depending on your lymphoma subtype, whether you are receiving treatment in the frontline or relapsed/refractory setting, and if you meet the appropriate eligibility criteria for a transplant. This presentation will provide information about the stem-cell transplant process for lymphoma patients and when this therapy may be available to you throughout your treatment course.
Speakers: Dr. Robert Puckrin
Dr. Robert Puckrin
Robert Puckrin is an academic hematologist at the Tom Baker Cancer Centre and University of Calgary with interests in the treatment of lymphoma, stem cell transplantation, CAR-T cell therapy and clinical research.